A market cap of $225M with sales of just over $7M and substantial losses. These guys need to start smashing out CardioCel sales because the market wont "wait a couple of years to gain CardioCel sales traction".
It may be the wonderful protect to improve the quality of life for those suffering from heart defects, but without the product being sold, the numbers wont stack up for much longer. And a couple of hundred thousand dollars in CardioCel sales wont justify its market cap.
Just my opinion.
News: Admedus revenue up 7.09% for FY2014, page-7
-
- There are more pages in this discussion • 35 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$18.00 |
Change
0.000(0.00%) |
Mkt cap ! $346.0M | |||
| Open | High | Low | Value | Volume |
| $18.00 | $18.10 | $17.70 | $58.64K | 3.27K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 109 | $18.00 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $18.10 | 700 | 1 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |